Why your GLP-1 dose feels fine one week and terrible the next

Dr. Ian Ellis explains why the number on your pen isn't the medicine in your body, why week five is when most people quit, and what it looks like to dose by how you feel.

Why the Same GLP-1 Dose Feels Different Every Week | A Doctor Explains

Ian Ellis took his first dose of semaglutide in 2021. The day after, he felt like the doors of heaven opened. For the first time in his life, he wasn't fighting his appetite. He could put food down and walk away. He still had energy. No side effects. He could still eat enough.

Week two, same dose, he didn't feel so good. Some GI trouble. A little food aversion the day after his second injection. Week three, worse. Week four, worse still. Week five, like a good patient, he doubled his dose to 0.5 mg.

Then he got really sick. And he never felt good again. He lost 30 lb, the easiest weight he'd ever dropped, but he felt terrible the whole time. He lost muscle mass, strength, and ended up a smaller, weaker, sicker version of himself.

The epiphany came when he remembered his first week and asked: why did it change? Why was week two different? Why did he get so sick on week five? The answer, it turns out, is just math.

I never felt good again after that. All the way down I lost 30 lb. It was the easiest weight I'd ever dropped. But I felt terrible the whole time.GLP-1 Hub

Your dose is not your medication level

A dose is a single input, the amount you inject right then. A medication level is the total amount of active medicine in your body at any moment. Your body responds to the level, not the dose.

The half-life for semaglutide is about a week. For tirzepatide, a little over five days. Half-life is how long it takes your body to use up half of what you injected.

Say you take 1 mg of a drug with a week-long half-life. Your level peaks around 1 mg. A week later, half is still in your body: 0.5 mg. You inject another 1 mg. Now your level is 1.5 mg, 50% higher than week one.

Week three: 0.75 mg is left, you add 1 mg, now you're at 1.75 mg. It takes about five doses to stabilize. That means in your first month at the same dose, you have four distinct medication levels. Four distinct experiences.

Just as you start to stabilize at week five, the standard protocol tells you to double your dose. The climb starts all over again.

You stay at the same dose, but you still have a stronger medication experience. That's kind of weird, right?GLP-1 Hub

Why this matters if you haven’t started yet: If you felt great on week two but terrible by week four, you didn't fail. The medicine was still climbing inside you.

Why week five is when most people quit

Statistically, most people who quit a GLP-1 do it around week five. That's when the standard protocol tells you to double your dose, right as your body was beginning to stabilize.

If you follow the Mounjaro or Zepbound ladder from 2.5 mg all the way to 15 mg, you will have 20 unique, individual medication experiences. You're chasing a moving target in the dark.

Ellis ran a clinic cohort of 114 patients for a year, manually calculating their real-time drug levels and adjusting doses to keep them in a sweet spot. They lost weight faster than the trials predicted, took an average of 50% of the standard dose, and zero patients dropped out due to side effects.

One patient, Mary Alice, wanted to lose 25 lb but was terrified of side effects. She started on a third of the starting dose and got violently sick for three days. Her second dose was a tenth of the starting dose. She never had another bad day, lost the weight at a pound and a half per week, and never even reached the 2.5 mg starting dose.

Zero patients dropped out due to side effects. Not a single person quit because of side effects.GLP-1 Hub

Why this matters if you haven’t started yet: The standard ladder isn't designed for you. It's designed to prove efficacy on a population. It has nothing to say to the individual.

What the sweet spot actually feels like

Ellis defines the GLP-1 sweet spot this way: you still get hungry sometimes. When you eat, you get full fast. You can still get enough protein and nutrition. You're not having side effects.

That's the medicine doing its job. That's all it's supposed to do.

If you've hit that sweet spot and you plateau, the answer is not to crank the dose higher until you can't eat. The medicine has already controlled your appetite. Look somewhere else: exercise, diet quality, hormones, something underlying.

Once you reach satisfactory appetite suppression, the medicine has done its job. Pounding the GLP-1 button harder won't fix a plateau. It will just make you sick.

Once you've found that sweet spot, if you're plateaued, it's not the medicine's fault. There's something else going on.GLP-1 Hub

Why end-of-week hunger isn't a reason to go up

You hit a peak level about a day after your injection. Then you slowly tail off. By the end of the week, you're starving. You eat back all your losses.

A primary care doctor would tell you to increase your dose. But your peak was already too high. You couldn't eat on day one. Increasing will just make the side effects worse.

Ellis's answer: keep your peak the same, or even drop it a little. Find the point where hunger comes back and dose from there. For some people, that's 2 mg every five days. For others, 6 mg every seven days. For very sensitive people, a small dose every three days.

Fixed-dose pens from Lilly and Novo Nordisk make this impossible. To do precision dosing, you need a multi-dose compounded vial or an adjustable pen like the KwikPen for tirzepatide.

Why this matters if you haven’t started yet: If you can't eat on day one but you're ravenous by day six, the problem isn't the dose. It's the interval.

Using an app like a thermostat for appetite

Ellis built an app that logs every dose you take, calculates your real-time drug level, and tells you exactly how much to inject to hit a target level you set yourself.

If you want a little more control, you nudge the target up, not from 71 to 120, but from 71 to 72. If last week was too strong, you turn it down a little. It's a thermostat for your appetite.

The app is only available under medical supervision, through his clinic or about 20 to 30 other clinics using the technology. Your prescription is a cap. You can take less, and you can take it more frequently, as long as your total stays under the script.

By definition, taking less medicine is safer than taking more. The goal is maximum patient autonomy and maximum safety.

Precision medicine, small frequent adjustments to stay in a sweet spot, can never be clinician dependent. What doctor has the ability to manage micro adjustments on a weekly basis for a thousand patients?GLP-1 Hub

Maintenance, travel, and cycling on and off

Ellis is on a GLP-1 about a third of the year. When his life is under control, his schedule is good, and he's not traveling or stressed, he doesn't need it to maintain his weight. Holidays, travel, work stress, he cycles back on.

He titrates up until his hunger is controlled, then adjusts dose by dose based on where he's at. If there's a special occasion and he wants room to eat more, he can dial it down.

For someone on maintenance who wants to find the lowest possible dose, he recommends logging the last five weeks of doses, then decreasing the target level by 2% each dose until hunger gets out of control. Then nudge it back up. That's your level for now.

For travel: take a dose right before you leave that gets you back to where you want to be for your trip, then another dose at the end. The app calculates how much. No more overdosing by injecting early or underdosing by waiting too long.

Why this matters if you haven’t started yet: Some people need these medicines every week for life. Some just need them occasionally. The point is you should be able to choose what works for you at this point in your life.

Notice what Ellis didn't say: that you need to race to the top, that you need to tough out side effects, that week five means you must go up. Every adjustment he describes is about staying where you feel good, not climbing a ladder designed for a clinical trial.

The standard dosing protocol makes 40% of people quit in the first month. Most who quit do it at week five. When you understand the math, it's obvious. They overshot, took too much, felt terrible. They should have been given the opportunity to stop the climb when they felt good.

Questions people ask

Why does my GLP-1 feel different every week even at the same dose?

Because your medication level keeps climbing even when your dose stays the same. With a half-life of about a week for semaglutide and five days for tirzepatide, half of last week's dose is still in your body when you inject again. It takes about five doses to stabilize, so you have four distinct experiences in your first month.

Can I adjust my GLP-1 dose without calling my doctor every time?

Under medical supervision and within boundaries, yes. Ellis's clinic uses an app that calculates real-time medication levels and adjusts dosing within the prescription cap. Your script is the ceiling; anything under that is safer by definition. Some clinics are now trained in this method.

What if I can't eat on day one but I'm starving by the end of the week?

Don't increase your dose. Your peak is already too high. Instead, keep the peak the same or lower it slightly, and shorten the interval between injections. For some people that's every five days, for others every three. The goal is to stay in the sweet spot, not spike higher.

GH
GLP-1 Hub

Dr. Ian Ellis is a board-certified physician, former ER doctor for 10 years, and founder of Vofit, a concierge telemedicine practice focused on precision GLP-1 dosing. He lost 30 lb on semaglutide and now manages hundreds of patients using an app he built to calculate real-time medication levels. 85,217 views on the original video.

Watch the original on YouTube →

Trending Topics

Free, from GLP‑1 Classified

Thinking about a GLP‑1? Read our guide before you start.

The questions to ask, the costs nobody mentions, and what the first month really feels like. Plus a short weekly letter for people on, or considering, a GLP‑1. We are not a pharmacy or a telehealth brand. We work for you, not for them.

No spam. Unsubscribe any time.